AP-7 (drug)

AP-7 is a compound that acts as an antagonist for the NMDA receptor. It is a selective, competitive glutamate antagonist that is often used in scientific research.

Pharmacology

AP-7 is a competitive antagonist for the NMDA receptor, a type of ionotropic glutamate receptor. It acts by binding to the same site on the receptor as the natural ligand glutamate, preventing glutamate from activating the receptor.

Uses in Research

Due to its selective action on the NMDA receptor, AP-7 is often used in scientific research to study the role of this receptor in various processes. For example, it has been used to investigate the role of the NMDA receptor in neuroplasticity, learning and memory, and the development of tolerance and dependence to opioids.

Side Effects

As with any drug, AP-7 can have side effects. These can include neurotoxicity, which can lead to neuronal death. However, these side effects are generally only seen at high doses.

See Also

• NMDA receptor antagonist
• Glutamate receptor
• Neuropharmacology

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• 
  AP-7 (drug)